Clinuvel Pharmaceuticals Limited (CLVLF)
USD 7.45
(0.0%)
USD 7.45
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 10.62 Million AUD | 11.63% |
| 2023 | 9.51 Million AUD | 419.65% |
| 2022 | 1.83 Million AUD | -42.51% |
| 2021 | 3.18 Million AUD | 147.43% |
| 2020 | 1.28 Million AUD | -39.71% |
| 2019 | 2.13 Million AUD | 233.09% |
| 2018 | 641.28 Thousand AUD | -48.35% |
| 2017 | 1.24 Million AUD | 14.73% |
| 2016 | 1.08 Million AUD | 29.27% |
| 2015 | 837.13 Thousand AUD | 259.1% |
| 2014 | -526.15 Thousand AUD | -52615500.0% |
| 2013 | 1.00 AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | -100.0% |
| 2006 | 579.91 Thousand AUD | 1719.46% |
| 2005 | 31.87 Thousand AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 93.00 AUD | 114.46% |
| 2001 | -643.00 AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 12.55 Million AUD | 31.94% |
| 2024 Q2 | 12.55 Million AUD | 0.0% |
| 2024 Q4 | 10.62 Million AUD | 0.0% |
| 2024 FY | 10.62 Million AUD | 11.63% |
| 2023 Q2 | 4.46 Million AUD | 0.0% |
| 2023 Q3 | 9.51 Million AUD | 113.32% |
| 2023 Q1 | 4.46 Million AUD | 143.6% |
| 2023 Q4 | 9.51 Million AUD | 0.0% |
| 2023 FY | 9.51 Million AUD | 419.65% |
| 2022 Q2 | 3.14 Million AUD | 0.0% |
| 2022 Q4 | 1.83 Million AUD | 0.0% |
| 2022 Q1 | 3.14 Million AUD | -1.25% |
| 2022 Q3 | 1.83 Million AUD | -41.79% |
| 2022 FY | 1.83 Million AUD | -42.51% |
| 2021 FY | 3.18 Million AUD | 147.43% |
| 2021 Q4 | 3.18 Million AUD | 0.0% |
| 2021 Q1 | 1.31 Million AUD | 2.19% |
| 2021 Q3 | 3.18 Million AUD | 142.12% |
| 2021 Q2 | 1.31 Million AUD | 0.0% |
| 2020 Q3 | 1.28 Million AUD | -32.57% |
| 2020 Q2 | 1.91 Million AUD | 0.0% |
| 2020 FY | 1.28 Million AUD | -39.71% |
| 2020 Q1 | 1.91 Million AUD | -10.58% |
| 2020 Q4 | 1.28 Million AUD | 0.0% |
| 2019 Q4 | 2.13 Million AUD | 0.0% |
| 2019 Q1 | 446.49 Thousand AUD | -30.37% |
| 2019 Q2 | 446.49 Thousand AUD | 0.0% |
| 2019 Q3 | 2.13 Million AUD | 378.41% |
| 2019 FY | 2.13 Million AUD | 233.09% |
| 2018 Q3 | 641.28 Thousand AUD | -40.93% |
| 2018 Q4 | 641.28 Thousand AUD | 0.0% |
| 2018 Q1 | 1.08 Million AUD | -12.57% |
| 2018 FY | 641.28 Thousand AUD | -48.35% |
| 2018 Q2 | 1.08 Million AUD | 0.0% |
| 2017 Q4 | 1.24 Million AUD | 0.0% |
| 2017 FY | 1.24 Million AUD | 14.73% |
| 2017 Q3 | 1.24 Million AUD | -8.27% |
| 2017 Q2 | 1.35 Million AUD | 0.0% |
| 2017 Q1 | 1.35 Million AUD | 25.08% |
| 2016 FY | 1.08 Million AUD | 29.27% |
| 2016 Q4 | 1.08 Million AUD | 0.0% |
| 2016 Q3 | 1.08 Million AUD | -20.31% |
| 2016 Q2 | 1.35 Million AUD | 0.0% |
| 2016 Q1 | 1.35 Million AUD | 62.22% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | 837.13 Thousand AUD | 259.1% |
| 2015 Q1 | - AUD | 100.0% |
| 2015 Q4 | 837.13 Thousand AUD | 0.0% |
| 2015 Q3 | 837.13 Thousand AUD | 0.0% |
| 2014 FY | -526.15 Thousand AUD | -52615500.0% |
| 2014 Q2 | 1.00 AUD | 0.0% |
| 2014 Q1 | 1.00 AUD | 0.0% |
| 2014 Q3 | - AUD | -100.0% |
| 2014 Q4 | -526.15 Thousand AUD | 0.0% |
| 2013 Q4 | 1.00 AUD | 0.0% |
| 2013 Q3 | 1.00 AUD | 0.0% |
| 2013 FY | 1.00 AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | -100.0% |
| 2006 FY | 579.91 Thousand AUD | 1719.46% |
| 2006 Q4 | 579.91 Thousand AUD | 0.0% |
| 2005 Q4 | 31.87 Thousand AUD | 0.0% |
| 2005 FY | 31.87 Thousand AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2002 FY | 93.00 AUD | 114.46% |
| 2001 FY | -643.00 AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |